To save researchers time and resources, The Michael J. Fox Foundation has made a number of tools available to the scientific community at low cost, with rapid delivery.
Helpful Resources
-
Sponsored Tools Program
Learn more about how MJFF can help share your tools.
-
Tools Consortium
MJFF is working with industry to develop priority tools.
-
Preclinical Models
Learn more about the various in vivo models used in Parkinson's disease research.
Find a Research Tool
Filter by Tool Type or Gene/Protein Type to Organize Results
* = MJFF does not control pricing or terms of availability for this tool.
-
GALC Antibody
Rabbit monoclonal antibody directed against human/mouse GALC for immunoblotting and immunostaining applications.
Estimated Availability: Early 2025
-
SCD5 Antibody
Rabbit monoclonal antibody directed against human SCD5 for immunoblotting and immunostaining applications.
Estimated Availability: Early 2025
-
Rab 12 pS106 Phosphospecific Antibody
Rabbit monoclonal antibody directed against human/mouse Rab12 phospho-S106 for immunoprecipitation and immunostaining applications.
Estimated Availability: Early 2025
-
RILPL2 Antibody
Rabbit monoclonal antibody directed against human/mouse RILPL2 for immunoblotting and immunostaining applications.
Estimated Availability: Early 2025
-
Auxilin Antibody
Rabbit monoclonal antibody directed against human/mouse auxilin for immunostaining applications.
Estimated Availability: Early 2025
-
Miro1 Antibody
Rabbit monoclonal antibody directed against human/mouse Miro1 for immunoblotting and immunostaining applications.
Estimated Availability: Early 2025
-
VPS13C Antibody
Rabbit monoclonal antibody directed against human/mouse VPS13C for immunoblotting and immunostaining applications.
Estimated Availability: Early 2025
-
INPP5F Antibody
Rabbit monoclonal antibody directed against human/mouse INPP5F for immunoblotting and immunostaining applications.
Estimated Availability: Early 2025
Email tools@michaeljfox.org with questions and to suggest new tools for us to develop. Or visit our FAQ page.